Atlanta Capital Management Co. L L C raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,464,104 shares of the medical instruments supplier’s stock after acquiring an additional 33,162 shares during the quarter. DENTSPLY SIRONA comprises approximately 1.8% of Atlanta Capital Management Co. L L C’s investment portfolio, making the stock its 16th biggest holding. Atlanta Capital Management Co. L L C owned approximately 2.38% of DENTSPLY SIRONA worth $326,808,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Chevy Chase Trust Holdings Inc. increased its position in DENTSPLY SIRONA by 1.3% in the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 204,539 shares of the medical instruments supplier’s stock valued at $12,234,000 after acquiring an additional 2,681 shares in the last quarter. Alyeska Investment Group L.P. increased its position in DENTSPLY SIRONA by 223.7% in the 3rd quarter. Alyeska Investment Group L.P. now owns 2,271,534 shares of the medical instruments supplier’s stock valued at $135,860,000 after acquiring an additional 1,569,746 shares in the last quarter. Jackson Square Partners LLC increased its position in DENTSPLY SIRONA by 15.6% in the 3rd quarter. Jackson Square Partners LLC now owns 6,334,906 shares of the medical instruments supplier’s stock valued at $378,890,000 after acquiring an additional 855,199 shares in the last quarter. Saturna Capital CORP increased its position in DENTSPLY SIRONA by 0.5% in the 3rd quarter. Saturna Capital CORP now owns 216,140 shares of the medical instruments supplier’s stock valued at $12,927,000 after acquiring an additional 1,140 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. increased its position in DENTSPLY SIRONA by 3.2% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 35,614 shares of the medical instruments supplier’s stock valued at $2,130,000 after acquiring an additional 1,111 shares in the last quarter. Hedge funds and other institutional investors own 96.58% of the company’s stock.

In other news, insider Mark Thierer acquired 77,000 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, November 13th. The shares were acquired at an average price of $66.04 per share, with a total value of $5,085,080.00. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Nicholas W. Alexos acquired 50,000 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, November 13th. The shares were purchased at an average cost of $65.85 per share, for a total transaction of $3,292,500.00. The disclosure for this purchase can be found here. 1.99% of the stock is owned by company insiders.

XRAY has been the subject of several research reports. BidaskClub cut shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Friday, October 20th. Cleveland Research cut shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research report on Thursday, October 5th. Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price objective for the company in a research report on Monday, November 6th. Finally, UBS restated a “neutral” rating and issued a $59.00 price objective (down previously from $62.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $67.73.

Shares of DENTSPLY SIRONA Inc. (XRAY) opened at $64.99 on Friday. DENTSPLY SIRONA Inc. has a 1 year low of $52.53 and a 1 year high of $68.98. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. The company has a market cap of $14,970.00, a P/E ratio of 26.14, a PEG ratio of 2.60 and a beta of 1.31.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 EPS for the quarter, topping the consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The company had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $978.99 million. During the same quarter in the previous year, the company earned $0.66 EPS. DENTSPLY SIRONA’s revenue was up 5.8% on a year-over-year basis. research analysts expect that DENTSPLY SIRONA Inc. will post 2.66 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “DENTSPLY SIRONA Inc. (XRAY) Position Raised by Atlanta Capital Management Co. L L C” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/12/08/dentsply-sirona-inc-xray-position-raised-by-atlanta-capital-management-co-l-l-c.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.